Indies Pharma Jamaica Limited reported earnings results for the second quarter and six months ended April 30, 2024. For the second quarter, the company reported sales was JMD 301.4 million compared to JMD 231.52 million a year ago. Net income was JMD 70.22 million compared to JMD 28.36 million a year ago. Basic earnings per share from continuing operations was JMD 0.053 compared to JMD 0.021 a year ago.
For the six months, sales was JMD 570.78 million compared to JMD 487.16 million a year ago. Net income was JMD 133.56 million compared to JMD 88.27 million a year ago. Basic earnings per share from continuing operations was JMD 0.1 compared to JMD 0.066 a year ago.